Asensus Surgical Files For FDA Nod For Additional Capabilities Of Laparoscopy System

by Vandana Singh, Benzinga Editor

July 14, 2021 7:32 AM | 1 min read |

Asensus Surgical Inc ASXC has filed a 510(k) submission with the FDA for an expansion of capabilities on the previously cleared Intelligent Surgical Unit (ISU).
The ISU is used on the Company's Senhance Surgical System, which enables digital laparoscopy.
The current features of the ISU enable machine vision-driven control of the camera for a surgeon. The new features would expand to include more advanced features to gather real-time data during surgery based on the anatomical structures in the surgical field.
Price Action: ASXC shares are up 5. 3% at $2.59 during the premarket session on the last check Wednesday.
Related content: Benzinga's Full FDA Calendar.

Posted In:

Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.